Under the agreement, Instituto Butantan will conduct registrational clinical trials of Replicate's novel srRNA rabies vaccine for post-exposure and pre-exposure prophylaxis Replicate to provide GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback